113 results
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
7 Nov 22
Ligand Reports Third Quarter 2022 Financial Results
4:04pm
antibody discovery business. I am excited for what lies ahead for Ligand and OmniAb as both execute their strategic goals as independent, publicly traded
425
EX-99.1
hmv7n7nhi5rhx52efvh
23 Mar 22
Business combination disclosure
5:29pm
8-K
EX-99.1
37txvs1ot7kpdjo59
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
j0yoett okukh
27 Jan 22
Departure of Directors or Certain Officers
4:02pm
8-K
0i19k5mxs24 gw
28 Jan 21
Entry into a Material Definitive Agreement
4:42pm
8-K
cz5 ffm101vrj8l82l
23 Dec 19
Departure of Directors or Certain Officers
4:06pm